课题基金 / 基金详情

项目摘要

项目成果

JAMES B MITCHELL的其他基金

相似基金

相关文献

中文摘要
翻译
为了改善癌症的治疗,人们对改变辐射损伤给予了相当大的关注。该项目的主要目标是继续定义和理解独特的肿瘤生理学、解剖学、细胞和分子过程的那些方面,这些方面最终定义了肿瘤的本质,从而使特定剂量的电离辐射在使用时更加有效。实现这一目标的一种方法是研究电离辐射与各种化疗药物的相互作用,以评估是否可以使肿瘤更敏感。我们先前证明,用紫杉醇治疗多种人类肿瘤细胞系可诱导细胞周期的G2/M(细胞周期的放射敏感期)阻滞,从而导致显著的放射敏感化。因此,将这些临床前信息转化为结合放疗和紫杉醇治疗头颈癌的临床试验目前正在放射肿瘤科进行。我们已经测试了其他化疗药物,包括MGI-114,一种新的烷基化倍半萜类化合物,在体外和体内模型中都显示出细胞毒性。我们已经证明,MGI-114选择性地使人乳腺和结肠细胞系对辐射致敏,并表明这种致敏与S期细胞周期阻滞有关。同样,另一种新型药物正在评估其放射致敏特性。Ecteinascidin 743是一种具有抗肿瘤活性的药物,可选择性地将鸟嘌呤N2烷基化,目前正在细胞培养中进行评估。该项目的另一个主要推力是开发功能成像技术,以更好地表征肿瘤微环境中可能阻止或减少影响辐射反应的药物的重要因素。众所周知,缺氧是辐射敏感性的主要决定因素。因此,我们正在使用几种小鼠肿瘤模型来研究肿瘤缺氧。我们的方法是使用当前的侵入性技术,并将信息扩展到正在开发的非侵入性方法,这样患者的肿瘤治疗概况就可以在个体的基础上进行优化。为此,我们使用了体外和体内存活技术、氧探针、硝基咪唑固定,然后是免疫组织化学、电子顺磁共振(EPR)和奥弗hauser MRI (OMRI)。目前,我们正在比较/对比这些不同的技术,目标是最终将无创EPR或OMRI功能成像带入临床试验。我们获得的信息将教会我们如何以非侵入性的方式评估肿瘤中的氧状态,以实现最佳治疗。我们最近比较了OMRI收集的小鼠肿瘤中的氧谱,并将结果与传统的氧电极测量结果进行了比较。OMRI氧谱图与氧电极测量有很好的相关性,因此验证了这种非侵入性技术用于组织中氧浓度评估。此外,我们正在开发一种使用EPR和稳定的顺磁探针(氮氧化物)对组织进行非侵入性氧化还原测绘的技术。总的来说,这些非侵入性功能成像方法应该增强我们更好地了解肿瘤微环境的能力,并制定有效攻击当前限制癌症治疗方式有效性的潜在障碍的策略。
英文摘要
In the interest of improving cancer treatment, considerable attention has been placed on the modification of radiation damage. The major goal of this project continues to define and understand those aspects of unique tumor physiology, anatomy, cellular, and molecular processes that ultimately define the very nature of a tumor such that a particular dose of ionizing radiation, when used will be more effective. One means to that end is to investigate the interaction of ionizing radiation with a variety of chemotherapy agents to assess if tumors can be made more sensitive. We previously demonstrated that treatment of diverse human tumor cell lines with paclitaxel induced a block in G2/M of the cell cycle (radiosensitive phases of the cell cycle) which resulted in significant radiosensitization. As a consequence, translation of this pre-clinical information into a clinical trail combining radiation and paclitaxel in the treatment of head/neck cancer is currently underway in the Radiation Oncology Branch. We have tested other chemotherapeutic agents including MGI-114, a new alkylating sesquiterpenoid which has shown cytotoxicity in both in vitro and in vivo models. We have shown that MGI-114 selectively radiosensitizes human breast and colon cell lines to radiation with an indication that the sensitization is related to cell cycle blocks in S phase. Likewise, another novel agent is being evaluated for radiosensitization properties. Ecteinascidin 743, an agent with anti-tumor activity that selectively alkylates guanine N2 is currently being evaluated in cell culture. Another major thrust of this project is to develop functional imaging techniques to better characterize factors important in the tumor microenvironment that may prevent or diminish agents from impacting radiation response. It is well established that hypoxia is a major determinant of radiation sensitivity. Therefore, we are using several murine tumor models to study tumor hypoxia. Our approach is to use current invasive techniques and extend that information to non-invasive methods that are under development, such that patient tumor treatment profiles may optimized on an individual basis. To that end we are using in vitro and in vivo survival techniques, oxygen probes, nitroimidazole fixation followed by immunohistochemistry, electron paramagnetic resonance (EPR), and Overhauser MRI (OMRI). Presently we are comparing/contrasting these various techniques with the goal of ultimately bringing non-invasive EPR or OMRI functional imaging to clinical trial. The information we acquire will teach us how to assess oxygen status in a tumor in a non-invasive manner to effect optimum treatment. We have recently compared oxygen profiles in mouse tumors collected by OMRI and compared the results with conventional oxygen electrode measurements. OMRI oxygen profiles correlate quite well with oxygen electrode measurements, thus validating this non-invasive technique for oxygen concentration assessment in tissues. Additionally, we are developing a technique of non-invasive redox mapping of tissues using EPR and a stable paramagnetic probe (nitroxide). Collectively, these non-invasive functional imaging approaches should enhance our ability to better understand the tumor microenvironment and develop strategies to effectively attack potential barriers that currently limit the effectiveness of cancer treatment modalities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of Therapeutic Response
Radiolysis, Photolysis, Sonolysis and Sonoprotection of
Nitroxides as Protectors Against Oxidative Stress
NITROXIDES AS PROTECTORS AGAINST OXIDATIVE STRESS
海外基金